[Burns and heparin therapy: prekallikrein and other hemostatic parameters].
作者信息
Hainaut J, Guilbaud J, Carsin H
出版信息
Agressologie. 1983 Nov;24(11):539-40.
PMID:6199993
Abstract
摘要
相似文献
1
[Burns and heparin therapy: prekallikrein and other hemostatic parameters].
Agressologie. 1983 Nov;24(11):539-40.
2
3
[Aspects of hemostasis and the immunology of burns].
Biomed Pharmacother. 1987;41(2):84-8.
4
Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
Acta Chir Scand. 1987 Mar;153(3):161-4.
5
Uncontrolled plasma proteolysis: a major threat to the septicemic patient.
Resuscitation. 1986 Sep;14(1-2):33-42. doi: 10.1016/0300-9572(86)90005-5.
6
Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
Am J Clin Pathol. 1984 Oct;82(4):396-404. doi: 10.1093/ajcp/82.4.396.
7
[Dynamics of proteolysis and the prekallikrein-kallikrein system of human blood plasma in burn injury].
Klin Khir (1962). 1984 Mar(3):22-5.
8
Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients.
Haemostasis. 1984;14(2):218-22. doi: 10.1159/000215059.
9
[Function of the blood prekallikrein-kallikrein system of patients with terminal kidney failure as affected by hemosorption].
Urol Nefrol (Mosk). 1986 Nov-Dec(6):41-4.
10
Plasma prekallikrein, functional kallikrein inhibition, antithrombin III, plasminogen, kallikrein activity and proenzyme functional inhibition index in 172 acute ill surgical patients on admission.
Adv Exp Med Biol. 1986;198 Pt B:451-61. doi: 10.1007/978-1-4757-0154-8_58.
Zotero 插件